RIGL
Rigel Pharmaceuticals·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
RIGL fundamentals
Rigel Pharmaceuticals (RIGL) released its earnings on Nov 4, 2025: revenue was 69.46M (YoY +25.59%), beat estimates; EPS was 1.46 (YoY +105.63%), beat estimates.
Revenue / YoY
69.46M
+25.59%
EPS / YoY
1.46
+105.63%
Report date
Nov 4, 2025
RIGL Earnings Call Summary for Q3,2025
- Revenue Surge: Q3 2025 net product sales of $64.1 million (+65% YoY), driving total revenue to $69.5 million. Updated 2025 guidance: $285-$290 million, up 55%-59% YoY.
- Pipeline Momentum: R289 phase 1b dose expansion underway; olutasidenib advancing into glioma and first-line AML/MDS via strategic trials.
- Financial Strength: $27.9 million net income, $137.1 million cash, and cost control supporting growth.
- Strategic Expansion: Global partnerships (e.g., Kissei, Dr. Reddy’s) and collaborations (MD Anderson, Connect) fueling pipeline and commercial reach.
EPS
Revenue
Revenue & Expenses
RIGL has released its 2025 Q3 earnings report, with revenue of 69.46M, reflecting a YoY change of 25.59%, and net profit of 27.90M, showing a YoY change of 124.62%. The Sankey diagram below clearly presents RIGL's revenue sources and cost distribution.
Key Indicators
Rigel Pharmaceuticals (RIGL) key financial stats and ratios, covering profitability, financial health, and leverage.
Rigel Pharmaceuticals (RIGL)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Rigel Pharmaceuticals (RIGL)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Rigel Pharmaceuticals (RIGL)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Rigel Pharmaceuticals (RIGL) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Rigel Pharmaceuticals (RIGL) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from Rigel Pharmaceuticals's earnings call?Did Rigel Pharmaceuticals beat or miss consensus estimates last quarter?What does Rigel Pharmaceuticals do and what are its main business segments?What guidance did Rigel Pharmaceuticals's management provide for the next earnings period?What is Rigel Pharmaceuticals's gross profit margin?What were the key takeaways from Rigel Pharmaceuticals’s earnings call?What is the market's earnings forecast for Rigel Pharmaceuticals next quarter?What is the revenue and EPS growth rate for Rigel Pharmaceuticals year over year?
